Hanwha Group Shares Look Cheap – Earnings Quality Soars Hanwha Group is rated Buy as valuation looks cheap, but the main upside case is accelerating earnings, especially net profit up 79.5% YoY, with risk that it is one off. 2026년 09월 01일 English
Hana Financial Group Valuation Looks Attractive – Key PER Insight Hana Financial Group trades at a low 7.6 PER with steady YoY growth (+6.8% revenue, +7.3% profit); analysts rate it Buy, targeting about 162809 yen as ROE durability could re-rate the stock. 2026년 08월 31일 English
Hyundai Steel Stock Prices Normalization – Margin Rebound Potential Hyundai Steel shows sharp operating profit improvement and margin repair, supported by India import rotation and data center demand, but net income is still negative, making the turnaround uncertain despite a Buy rating and upside. 2026년 08월 31일 English
Kakao Stock Reprices After Earnings Beat: AI Monetization Kakao stock looks undervalued: analysts rate Buy as operating profit jumped 66% YoY, driven by AI for All distribution, though net profit and ROE remain concerns. 2026년 08월 28일 English
KG Mobility Stock Re-Rates as Chery Funding Boosts Insights KG Mobility shares get a Buy case as Chery-linked $75M funding and improving profitability drive net income sharply higher, though thin operating margin makes execution risk remain. 2026년 08월 28일 English
Samsung C&T Net Profit Jumps Despite Revenue Growth: Insight Samsung C&T earns buying consensus as revenue and net profit rise, despite slightly weaker operating profit; targets imply meaningful upside if margins stabilize. 2026년 08월 27일 English
Samsung Electro-Mechanics Re-Rating on Faster Earnings – AI Cycle Outlook Samsung Electro-Mechanics rated Buy: AI supply tightness boosts margins, with net income up 86% YoY while stock trades below analyst targets. 2026년 08월 27일 English
IBK Industrial Bank Holds Valuation but Faces Governance Risk IBK Industrial Bank rated Hold as cheap valuation is offset by China loan fraud and governance risk, causing profit decline and possible higher compliance costs. 2026년 08월 26일 English
Samsung Biologics Earnings Rally – Growth and Profit Insight Samsung Biologics has strong growth and high margins; analysts rate it a Buy with upside, but labor and production disruption risks keep volatility high. 2026년 08월 26일 English
POSCO Holdings Earnings Accelerate: Lithium Demand Boost POSCO Holdings is rated Buy as analysts see upside to targets, driven by accelerating profits, lithium-related execution, and improving margins, despite low ROE and thematic risks. 2026년 08월 25일 English
